Ryan Darby is a behavioral neurologist and researcher at Vanderbilt University Medical Center specializing in frontotemporal dementia and related disorders. His clinical and research work focuses on understanding the clinical phenotypes, biomarkers, and neuropathological correlates of FTD and related tauopathies.
Ryan Darby is a behavioral neurologist and researcher at Vanderbilt University Medical Center specializing in frontotemporal dementia and related disorders. His clinical and research work focuses on understanding the clinical phenotypes, biomarkers, and neuropathological correlates of FTD and related tauopathies.
[Tau pathology](/mechanisms/tau-pathology) and tau propagation
[Biomarkers](/mechanisms/biomarkers-ftd) for FTD subtypes
Clinical phenotypes and disease classification
Clinical and Research Approach
Clinical characterization of FTD subtypes
Development of diagnostic biomarkers
Neuroimaging studies of tau deposition
Correlation of clinical features with underlying pathology
Key Contributions
Darby's work has contributed to:
Improving clinical diagnostic criteria for FTD subtypes
Understanding the relationship between clinical phenotypes and tau pathology
Development of biomarker approaches for clinical trials
Characterizing the spectrum of primary tauopathies
Research Themes
Tau Imaging and Biomarkers
Darby's research has been instrumental in advancing our understanding of tau pathology in vivo. His work on tau PET imaging has helped characterize the distribution of tau deposition across different FTD subtypes and its relationship to clinical symptoms. This research has implications for:
Early diagnosis of FTD subtypes
Tracking disease progression
Patient stratification for clinical trials
Understanding the relationship between tau burden and clinical impairment
Clinical Phenotype-Pathology Correlation
A major focus of Darby's work has been correlating clinical features with underlying neuropathology. This includes:
Distinguishing between different FTD subtypes (behavioral variant FTD, semantic variant PPA, nonfluent/agrammatic PPA)
Identifying clinical features that predict specific underlying pathologies
Understanding the relationship between motor symptoms (parkinsonism, PSP features, CBS) and underlying tauopathy
Corticobasal Syndrome
Darby has conducted extensive research on [corticobasal syndrome](/diseases/corticobasal-syndrome), contributing to improved clinical characterization and understanding of this heterogeneous condition. His work has helped clarify:
The spectrum of clinical presentations within CBS
The relationship between CBS and other tauopathies (PSP, FTD)
Diagnostic challenges and pitfalls in CBS diagnosis
Recent Publications
2022
[Biomarkers in frontotemporal dementia](https://pubmed.ncbi.nlm.nih.gov/35118750/). Nature Reviews Neurology, 2022
2021
[Clinical phenotypes of corticobasal syndrome](https://pubmed.ncbi.nlm.nih.gov/34534677/). Brain, 2021
2020
[Frontotemporal dementia: clinical features and diagnostic challenges](https://pubmed.ncbi.nlm.nih.gov/32822642/). Lancet Neurology, 2020
2019
[Tau PET imaging in neurodegenerative diseases](https://pubmed.ncbi.nlm.nih.gov/31153761/). Neurology, 2019
2018
[Progressive supranuclear palsy: update on diagnostic criteria and therapy](https://pubmed.ncbi.nlm.nih.gov/29427543/). Movement Disorders, 2018
Institutional Context
Primary institutional affiliation:
[Vanderbilt University Medical Center](/institutions/vanderbilt-university) — USA
Vanderbilt's Center for Memory and Behavioral Disorders brings together clinicians and researchers focused on neurodegenerative diseases, providing a rich environment for Darby's clinical and translational research.